drugset / Trial / NCT02304627

Effect of Food on the Pharmacokinetics of NNC0123-0000-0338 in a Tablet Formulation in Healthy Subjects

NCT02304627

Phase 1 Completed 45 enrolled Novo Nordisk A/S
RandomizedCrossoverOpen-labelTreatment

Summary

This trial is conducted in Europe. The aim of the trial is to investigate the effect of food on the pharmacokinetics (the exposure of the trial drug in the body) of NNC0123-0000-0338 in a tablet formulation in healthy subjects.

Timeline

Start
2014-11-24
Primary completion
2015-07-31
Completion
2015-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin 338 Protein / enzyme biologic Oral

Indications